Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-014210
Filing Date
2013-03-04
Accepted
2013-03-04 19:47:08
Documents
1
Period of Report
2013-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 - HENWOOD - CLOSING rrd372400.html 4  
1 FORM 4 - HENWOOD - CLOSING rrd372400.xml 4 9186
  Complete submission text file 0001181431-13-014210.txt   10534
Mailing Address 88 SIDNEY ST CAMBRIDGE MA 02139
Business Address
HENWOOD GERALDINE (Reporting) CIK: 0001236451 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33719 | Film No.: 13663374

Mailing Address 2400 BAYSHORE PARKWAY, SUITE 200 MOUNTAIN VIEW CA 94043
Business Address 2400 BAYSHORE PARKWAY, SUITE 200 MOUNTAIN VIEW CA 94043 650-386-3100
MAP Pharmaceuticals, Inc. (Issuer) CIK: 0001401923 (see all company filings)

EIN.: 200507047 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations